HomeHealth articlesrefractory cytopeniaWhat Is Refractory Cytopenia?

Refractory Cytopenia- Lack of Blood Cells

Verified dataVerified data
0

4 min read

Share

Refractory cytopenia is a type of myelodysplastic syndrome, with a decrease in the number of blood cells. Read the article below to know more.

Written by

Dr. Aaliya

Medically reviewed by

Dr. Abdul Aziz Khan

Published At April 20, 2023
Reviewed AtApril 26, 2023

Introduction

Refractory cytopenia is an uncommon blood disorder that results in the reduction of the number of blood cells in the body, including red and white blood cells and platelets. It is usually diagnosed in elderly individuals with an average onset age of 70. The cause of the disorder is not well understood, but it is thought to be associated with abnormalities in the production of blood cells. Refractory cytopenia is a severe condition that necessitates continual monitoring and treatment by a medical team.

What Is Refractory Cytopenia?

Refractory cytopenia is a health condition that happens when the body does not make enough blood cells, like red and white blood cells and platelets. This condition is a type of myelodysplastic syndrome, which means there are problems with how the bone marrow produces blood cells.

What Are the Types of Refractory Cytopenia?

There are multiple types of refractory cytopenia, which are classified according to the type of blood cells affected and specific disease features. These include:

  • Refractory Anemia: It is characterized by low red blood cell counts and anemia.

  • Refractory Neutropenia: It is characterized by low white blood cell counts, particularly low neutrophil counts.

  • Refractory Cytopenia With Multilineage Dysplasia: It is characterized by abnormal or dysplastic cells in more than one type of blood cell.

It is important to remember that refractory cytopenia is a rare disease and can be challenging to diagnose, so it is essential to consult with a hematologist or other medical specialist if you suspect you may have this condition.

What Are the Symptoms of Refractory Cytopenia?

The indications of refractory cytopenia may vary depending on the specific blood cell type affected. Some general indications of refractory cytopenia comprise the following:

  • Fatigue.

  • Weakness.

  • Pale skin.

  • Shortness of breath.

  • Rapid or irregular heartbeat.

  • Easy bruising or bleeding.

  • Frequent infections.

  • Bone pain.

  • Abdominal swelling or discomfort.

  • Loss of appetite.

  • Weight loss.

It is essential to note that other conditions could also cause these symptoms, and not all individuals with refractory cytopenia will encounter them. If someone is having any of these symptoms, seeking medical attention for an accurate diagnosis and proper treatment is critical.

What Are the Causes of Refractory Cytopenia?

Refractory cytopenia can be caused by various factors, which include the following:

  • Bone Marrow Failure: The production of blood cells is the responsibility of the bone marrow. However, if the bone marrow fails to function properly due to certain disorders like myelodysplastic syndromes (MDS), aplastic anemia, or other bone marrow diseases, it can result in refractory cytopenia.

  • Exposure to Toxins: Exposure to certain toxins like benzene can damage the bone marrow.

  • Viral Infections: Viral infections like hepatitis or parvovirus B19 can cause bone marrow failure and lead to refractory cytopenia.

  • Autoimmune Disorders: An autoimmune disorder may lead to refractory cytopenia, as the immune system may attack the bone marrow and hinder its ability to produce blood cells.

  • Genetic Mutations: Rare genetic mutations affecting blood cell production can also cause refractory cytopenia.

What Are the Conditions That Are Associated With Refractory Cytopenia?

The specific conditions associated with refractory cytopenia are as under:

  • Refractory Anemia: It is marked by insufficient red blood cells, which can result in symptoms such as fatigue, weakness, and shortness of breath.

  • Refractory Neutropenia: It involves a low count of a particular type of white blood cells known as neutrophils, thereby increasing the likelihood of infections.

  • Refractory Thrombocytopenia: It is characterized by a scarcity of platelets, leading to unusual bleeding and bruising.

How to Diagnose Refractory Cytopenia?

Refractory cytopenia is typically diagnosed through clinical evaluation, laboratory tests, and bone marrow biopsy. The following are the diagnostic criteria for refractory cytopenia:

  • Persistent Cytopenia: A patient must have at least one type of cytopenia (low red blood cell count, low platelet count, or low white blood cell count) present for at least six months.

  • Absence of Blasts: The bone marrow must contain less than 5 % blasts, and the peripheral blood smear must show no blasts.

  • Dysplasia: The bone marrow must show dysplasia in at least one of the major cell lines.

  • Exclusion of Other Causes: Other causes of cytopenia, such as vitamin deficiencies, autoimmune diseases, or infections, must be ruled out.

To help diagnose refractory cytopenia, the following tests may be ordered:

  • Blood Tests: A complete blood count (CBC) can reveal low blood cell counts. Other blood tests can help rule out other causes of cytopenia.

  • Bone Marrow Biopsy: This is the most important test for diagnosing MDS (myelodysplastic), and it can reveal dysplasia and the presence of blasts.

  • Cytogenetic Analysis: This test looks for chromosomal abnormalities in the bone marrow cells.

  • Flow Cytometry: This test can detect small numbers of abnormal cells that may not be visible under the microscope.

If the above criteria are met, and other potential causes of cytopenia are ruled out, refractory cytopenia can be diagnosed.

How to Treat the Condition of Refractory Cytopenia?

Treatment options for refractory cytopenia depend on the underlying cause and blood cell type.

  • Medications: Doctors may prescribe drugs that promote blood cell production or target an underlying condition. Examples include erythropoietin-stimulating agents (ESAs) to increase red blood cells, and granulocyte-colony stimulating factor (G-CSF) to increase white blood cells.

  • Blood Transfusions: Severe cytopenia may require blood transfusions to boost red blood cells, white blood cells, or platelets in circulation.

  • Bone Marrow Transplant: When appropriate, a bone marrow transplant can replace a person's unhealthy bone marrow with a healthy donor to jumpstart blood cell production.

  • Supportive Care: Medical treatments may be supplemented with a nutritious diet, exercise, and stress management to improve overall health and blood cell formation.

Collaborating with a doctor to tailor the treatment plan according to the individual's medical history and specific needs is crucial.

Conclusion

Refractory cytopenia is a severe medical ailment that demands immediate identification and therapy. With proper medical supervision, individuals experiencing refractory cytopenia can alleviate their symptoms and enhance their standard of living. It is crucial for patients who are encountering symptoms of refractory cytopenia to promptly seek medical assistance and adhere to their doctor's recommendations regarding therapy and consistent care.

Source Article IclonSourcesSource Article Arrow
Dr. Abdul Aziz Khan
Dr. Abdul Aziz Khan

Medical oncology

Tags:

refractory cytopenia
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

refractory cytopenia

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy